403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Medicenna Therapeutics Corp.
(MENAFN- Baystreet) 09:33 AM EST - Medicenna Therapeutics Corp. : Today reported financial results and corporate highlights for the fiscal quarter ended June 30, 2025. For the three months ended June 30, 2025, the Company reported total operating costs of $5.5 million compared to total operating costs of $4.0 million for the three months ended June 30, 2024. Net loss for the quarter was $4.9 million or $0.06 per share compared to a net loss of $3.6 million or $0.05 per share for the three months ended June 30, 2024. Medicenna Therapeutics Corp.
shares T are trading unchanged at $0.84.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment